venetoclax,azacitidine,emavusertib
roche,curis,abbvie
['emavusertib', 'ca-4948', 'mds', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'venetoclax', 'aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', 'azacitidine,(-oral azaci),(-azacitidine oral)', 'leukemia']
takeaim leukemia- a phase 1/2a study of the irak4 inhibitor emavusertib (ca-4948) as monotherapy or in combination with azacitidine or venetoclax in relapsed/refractory #aml or #mds: summary #eha2022 
Professor of hematology, Universitary hospital of Sidi Bel Abbés.
Head, Hospitalisation and  Geriatric Unit.